DEXCOM INC is 25.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($28.85 B vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KMTS | DXCM |
|---|---|---|
| Market cap | $1.12 B | $28.85 B |
| US-listed rank | #2558 | #473 |
| Revenue (latest FY) | $59.81M | $4.66B |
| Net income (latest FY) | -$113.81M | $836.30M |
| Net margin | -190.3% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 105 | 2,566 |
DEXCOM INC is 25.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($28.85 B vs $1.12 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while DEXCOM INC reported $4.66B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and DEXCOM INC, or browse the full rankings.